Literature DB >> 25096624

Association between stroke and Alzheimer's disease: systematic review and meta-analysis.

Jing Zhou1, Jin-Tai Yu2, Hui-Fu Wang3, Xiang-Fei Meng4, Chen-Chen Tan4, Jun Wang4, Chong Wang4, Lan Tan2.   

Abstract

Alzheimer's disease (AD) and stroke are common disorders of aging, but the relationship between these two disorders remains uncertain. Recent evidence recognized that they frequently co-occur and are influenced by each other, while other studies have produced inconsistent results. We conducted this systematic review and meta-analysis of stroke on risk for AD and AD on risk for stroke subtypes to clarify the relation between these two disorders on the basis of the studies published from 1975 to November 2013 in the PubMed, EMBASE, and Cochrane Library databases. In total, 7 cohort studies and 2 nested case-control studies met the inclusion criteria for meta-analysis. For stroke, the pooled effect size for AD risk was 1.59 (95% CI 1.25-2.02; z = 3.76; p = 0.000). For AD dementia, it was not associated with risk of all strokes or ischemic stroke (IS), but the risk of intracerebral hemorrhage (ICH was higher among persons with AD. The pooled RR for AD in relation to incident IS did not indicate a significant association (RR: 1.13; 95% CI 0.75-1.70; z = 0.58; p = 0.565). The pooled effect size for AD and ICH risk was 1.41 (95% CI 1.21-1.66; z = 4.27; p < 0.001). Stroke significantly and independently increased risk for AD and in turn AD increased risk for ICH. These results confirm that AD and ICH may have common pathogenesis and share preventive treatment measures.

Entities:  

Keywords:  Alzheimer's disease; meta-analysis; risk; stroke

Mesh:

Year:  2015        PMID: 25096624     DOI: 10.3233/JAD-140666

Source DB:  PubMed          Journal:  J Alzheimers Dis        ISSN: 1387-2877            Impact factor:   4.472


  39 in total

1.  Cerebral Blood Flow Is Associated with Diagnostic Class and Cognitive Decline in Alzheimer's Disease.

Authors:  Wenna Duan; Parshant Sehrawat; Arvind Balachandrasekaran; Ashish B Bhumkar; Paresh B Boraste; James T Becker; Lewis H Kuller; Oscar L Lopez; H Michael Gach; Weiying Dai
Journal:  J Alzheimers Dis       Date:  2020       Impact factor: 4.472

2.  Chronic Hypertension Leads to Neurodegeneration in the TgSwDI Mouse Model of Alzheimer's Disease.

Authors:  Anna Kruyer; Nadine Soplop; Sidney Strickland; Erin H Norris
Journal:  Hypertension       Date:  2015-05-04       Impact factor: 10.190

Review 3.  Targeting amyloid clearance in Alzheimer's disease as a therapeutic strategy.

Authors:  Natalia N Nalivaeva; Anthony J Turner
Journal:  Br J Pharmacol       Date:  2019-03-11       Impact factor: 8.739

Review 4.  Role of Improved Vascular Health in the Declining Incidence of Dementia.

Authors:  Matthew P Pase; Claudia L Satizabal; Sudha Seshadri
Journal:  Stroke       Date:  2017-06-08       Impact factor: 7.914

Review 5.  One is the deadliest number: the detrimental effects of social isolation on cerebrovascular diseases and cognition.

Authors:  Brett Friedler; Joshua Crapser; Louise McCullough
Journal:  Acta Neuropathol       Date:  2014-12-24       Impact factor: 17.088

6.  Stroke and dementia risk: A systematic review and meta-analysis.

Authors:  Elżbieta Kuźma; Ilianna Lourida; Sarah F Moore; Deborah A Levine; Obioha C Ukoumunne; David J Llewellyn
Journal:  Alzheimers Dement       Date:  2018-08-31       Impact factor: 21.566

Review 7.  Mechanisms of Dysfunction in the Aging Vasculature and Role in Age-Related Disease.

Authors:  Anthony J Donato; Daniel R Machin; Lisa A Lesniewski
Journal:  Circ Res       Date:  2018-09-14       Impact factor: 17.367

8.  Protective effect of the multitarget compound DPH-4 on human SSAO/VAP-1-expressing hCMEC/D3 cells under oxygen-glucose deprivation conditions: an in vitro experimental model of cerebral ischaemia.

Authors:  P Sun; G Esteban; T Inokuchi; J Marco-Contelles; B B Weksler; I A Romero; P O Couraud; M Unzeta; M Solé
Journal:  Br J Pharmacol       Date:  2015-10-27       Impact factor: 8.739

9.  Common Impact of Chronic Kidney Disease and Brain Microhemorrhages on Cerebral Aβ Pathology in SHRSP.

Authors:  Daniel Pirici; Luiza Stanaszek; Cornelia Garz; Solveig Niklass; Hans-Jochen Heinze; Thomas Kalinski; Johannes Attems; Stefanie Schreiber
Journal:  Brain Pathol       Date:  2016-05-30       Impact factor: 6.508

Review 10.  Protein Aggregation in the Pathogenesis of Ischemic Stroke.

Authors:  Shusheng Wu; Longfei Du
Journal:  Cell Mol Neurobiol       Date:  2020-06-11       Impact factor: 5.046

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.